chemXplore tracks 64 projects in Finland, of which 32 are active.
Of the active ones, 25 new construction, 4 expansion, 2 revamp / retrofit and 1 conversion / repurposing.
4 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
China’s regulator approved a plant-based, water‑soluble CMC excipient for pharmaceutical manufacturing, enabling supply into China’s large drug production market.
200–300 MW Kotka plant will make power from natural gas without CO2 by splitting methane into hydrogen and solid carbon for combustion and industrial use.
€1bn Europe-wide auction for industrial process-heat decarbonisation; bidding opens early Dec 2026. Supports electrification, renewable heat and SMRs with a fixed premium per tCO2.
CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.
SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.
Long-term H2PPAs secure physical renewable power and Guarantees of Origin for RFNBO-compliant hydrogen, enabling flexible e‑methane production and advancing the project's FID.
Plans target 20,000 t/yr hydrogen and ~60,000 t/yr graphite using methane decomposition; ties into MESH long‑duration storage to capture surplus wind power and cut emissions.
Integrated technology chain will turn renewable electricity and captured biogenic CO2 into e‑methane, using electrolysis, methanation, hydrogen handling and waste-heat recovery to district heating.
Planned Rauma plant would capture 100,000 tCO2/yr from pulp‑mill flue gas for use in e‑fuels; funding clears a key investment hurdle.
Two executives named for CEO and CFO of planned graphic paper joint venture; appointments hinge on regulatory approvals and closing.
active / all projects
